Determinants of late disease-stage presentation at diagnosis of HIV infection in Venezuela: A case-case comparison

被引:41
作者
Bonjour M.A. [1 ,2 ]
Montagne M. [3 ]
Zambrano M. [3 ]
Molina G. [3 ]
Lippuner C. [1 ,4 ]
Wadskier F.G. [5 ]
Castrillo M. [3 ]
Incani R.N. [5 ]
Tami A. [1 ,5 ,6 ]
机构
[1] Department of Biomedical Research, Royal Tropical Institute, Amsterdam
[2] Department of Epidemiology and Biostatistics, Radboud University Nijmegen Medical Centre, Nijmegen
[3] Centre for Integral Attention for Sexually Transmitted Diseases and HIV/AIDS, National Program of HIV/AIDS, Ministry of Health and Social Development, Valencia
[4] Department of Biology and Society, Faculty of Earth and Life Sciences, Free University of Amsterdam, Amsterdam
[5] Department of Parasitology, Faculty of Health Sciences, University of Carabobo, Valencia
[6] Centre of Information Technology, Communication and Assisted Education, Faculty of Health Sciences, University of Carabobo, Valencia
关键词
Human Immunodeficiency Virus; Risk Perception; Late Presentation; Human Immunodeficiency Virus Testing; Human Immunodeficiency Virus Status;
D O I
10.1186/1742-6405-5-6
中图分类号
学科分类号
摘要
Background: Although Venezuela has a National Human Immunodeficiency Virus (HIV) Program offering free diagnosis and treatment, 41% of patients present for diagnosis at a later disease-stage, indicating that access to care may still be limited. Our study aimed to identify factors influencing delay in presenting for HIV-diagnosis using a case-case comparison. A cross-sectional survey was performed at the Regional HIV Reference Centre (CAI), Carabobo Region, Venezuela. Between May 2005 and October 2006 225 patients diagnosed with HIV at CAI were included and demographic, behavioural and medical characteristics collected from medical files. Socio-economic and behavioural factors were obtained from 129 eligible subjects through interviews. "Late presentation" at diagnosis was defined as patients classified with disease-stage B or C according to the 1993 Centers for Disease Control and Prevention (Atlanta, USA) classification, and "early presentation" defined as diagnosis in disease-stage A. Results: Of 225 subjects, 91 (40%) were defined as late presenters. A similar proportion (51/129) was obtained in the interviewed sub-sample. Older age (>30 years), male heterosexuality, lower socio-economic status, perceiving ones partner to be faithful and living ≥ 25 km from the CAI were positively associated with late diagnosis in a multivariate model. Females were less likely to present late than heterosexual males (odds ratio = 0.23, P = 0.06). The main barriers to HIV testing were low knowledge of HIV/AIDS, lack of awareness of the free HIV program, lack of perceived risk of HIV-infection, fear for HIV-related stigma, fear for lack of confidentiality at testing site and logistic barriers. Conclusion: Despite the free Venezuelan HIV Program, poverty and barriers related to lack of knowledge and awareness of both HIV and the Program itself were important determinants in late presentation at HIV diagnosis. This study also indicates that women; heterosexual, bisexual and homosexual men might have different pathways to testing and different factors related to late presentation in each subgroup. Efforts must be directed to i) increase awareness of HIV/AIDS and the Program and ii) the identification of specific factors associated with delay in HIV diagnosis per subgroup, to help develop targeted public health interventions improving early diagnosis and prognosis of people living with HIV/AIDS in Venezuela and elsewhere. © 2008 Bonjour et al; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 181 条
  • [1] Carrasco E(2000)Access to treatment as a right to life and health Can HIV AIDS Policy Law Rev 5 102-103
  • [2] Chadborn TR(2005)No time to wait: how many HIV-infected homosexual men are diagnosed late and consequently die? (England and Wales, 1993-2002) Aids 19 513-520
  • [3] Baster K(2002)Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies Lancet 360 119–129-1951
  • [4] Delpech VC(2001)HIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active antiretroviral therapy AIDS 15 2251–57-1665
  • [5] Sabin CA(2002)Late diagnosis of HIV infection in the era of highly active antiretroviral therapy: consequences for AIDS incidence Aids 16 1945-469
  • [6] Sinka K(2003)Improved Outcomes with Earlier Initiation of Highly Active Antiretroviral Therapy Among Human Immunodeficiency VirusInfected Patients Who Achieve Durable Virologic Suppression: Longer Follow-Up of an Observational Cohort Study J Infect Dis 188 1659-1405
  • [7] Rice BD(2003)Temporal trend and factors associated with late HIV diagnosis in Hong Kong, a low HIV prevalence locality AIDS Patient Care STDS 17 461-1024
  • [8] Evans BG(1999)Effects of HIV counseling and testing on sexual risk behavior: a meta-analytic review of published research, 1985-1997 Am J Public Health 89 1397-585
  • [9] Egger M(2001)The Serostatus Approach to Fighting the HIV Epidemic: prevention strategies for infected individuals Am J Public Health 91 1019-98
  • [10] May M(2005)Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy N Engl J Med 352 570-2330